Vistagen Therapeutics Inc
(VTGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 334 | 0 | 0 | 0 | 0 |
| Gross Profit | 334 | N/A | N/A | N/A | N/A |
| Operating Expenses | 3,628 | 3,122 | 3,263 | 5,963 | 5,351 |
| Operating Income | -3,294 | -3,122 | -3,263 | -5,963 | -5,351 |
| Interest Expense | 4 | 3 | 3 | -2 | -15 |
| Other Income | 0 | 1 | 0 | 0 | 0 |
| Pre-tax Income | -3,298 | -3,124 | -3,267 | -5,961 | -5,336 |
| Income Tax | 0 | 2 | 5 | 0 | N/A |
| Net Income Continuous | -3,297 | -3,127 | -3,272 | -5,962 | -5,336 |
| Net Income | $-3,298 | $-3,127 | $-3,267 | $-5,962 | $-5,336 |
| EPS Basic Total Ops | -1.50 | -2.10 | -2.10 | -4.50 | -3.90 |
| EPS Basic Continuous Ops | -1.48 | -1.83 | -1.94 | -4.15 | -3.76 |
| EPS Diluted Total Ops | -1.50 | -2.10 | -2.10 | -4.50 | -3.90 |
| EPS Diluted Continuous Ops | -1.48 | -1.83 | -1.94 | -4.15 | -3.76 |
| EBITDA(a) | $-3,268 | $-3,096 | $-3,316 | $-5,951 | $-5,230 |